Subscribe
istock-629430458pablo_k-1-
Pablo_K / iStockphoto.com
29 August 2018Big Pharma

Horizon partners with big pharma company on CRISPR

UK-based Horizon Discovery has entered into a CRISPR collaboration with an unnamed big pharma company.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
Horizon Discovery expands CRISPR licence
17 January 2017   UK-based Horizon Discovery has broadened its gene editing capabilities through the amendment of a pre-existing licence with ERS Genomics to include the full commercial rights for the use of CRISPR.
Europe
Horizon Discovery expands CRISPR licence with ERS Genomics
5 December 2017   UK-based genomics company Horizon Discovery has expanded its licence coverage for use of the CRISPR gene-editing technology.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

More on this story

Biotechnology
Horizon Discovery expands CRISPR licence
17 January 2017   UK-based Horizon Discovery has broadened its gene editing capabilities through the amendment of a pre-existing licence with ERS Genomics to include the full commercial rights for the use of CRISPR.
Europe
Horizon Discovery expands CRISPR licence with ERS Genomics
5 December 2017   UK-based genomics company Horizon Discovery has expanded its licence coverage for use of the CRISPR gene-editing technology.

More on this story

Biotechnology
Horizon Discovery expands CRISPR licence
17 January 2017   UK-based Horizon Discovery has broadened its gene editing capabilities through the amendment of a pre-existing licence with ERS Genomics to include the full commercial rights for the use of CRISPR.
Europe
Horizon Discovery expands CRISPR licence with ERS Genomics
5 December 2017   UK-based genomics company Horizon Discovery has expanded its licence coverage for use of the CRISPR gene-editing technology.

More features

K&L Gates adds litigator in Melbourne
Gowling WLG’s legal director jumps to Osborne Clarke
Novartis wins appeal in MSN clash over heart drug generic
Takeda loses AMR treatment patent used in kidney transplants
Withers & Rogers hires cell and gene therapy expert
Medtech firm strikes out part of Apple button patent in ECG row
Tissue repair VP gets new trial over secrets damages
Labcorp's bid to invalidate Ravgen's DNA testing patent hits roadblock